DAVA Oncology Competitors and Similar CompaniesClear all

Corvus Pharmaceuticals's competitors and similar companies include GlycoMimetics.

	Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.	GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Founding Date	Founding Date 2014	Founding Date 2003
Type	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Burlingame, US HQ	Locations Rockville, US HQ
Employees	Employees 4911% decrease	Employees 5025% increase
Valuation ($)	Valuation ($) 556.1 m	Valuation ($) 31.6 m
Financial
Net income	Net income ($15.3m) (FY, 2025)	Net income ($153.9m) (FY, 2025)

For sources of this data, please see the company profile

Rockville, US

Employees

50↑ 25% increase

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

Financial